EasyDNNNewsCalendar

Archive

EasyDNNNews

Review Finds Radiotherapy May Convert Breast Cancer Into In Situ Vaccine.

Wednesday, December 6, 2017

Cancer Therapy Advisor (12/6, Furlow) reports on a “review of preclinical and early human trial data” presented at the San Antonio Breast Cancer Symposium finding that “radiotherapy’s pro-immunogenic effects might improve the antitumor efficacy of immune checkpoint inhibition.” Silvia Formenti, MD, of Weill Cornell Medicine, in New York, New York, said, “Most breast cancers may require multiple immunotherapeutic interventions to become an in situ vaccine.” Dr. Formenti said that the review supports using “3 to 5 doses of 8 Gy each when radiotherapy is combined with immunotherapy.

Abbreviated MRI Presented As Means To Improve Diagnosis Of Breast Cancer.

Thursday, November 30, 2017

Medscape (11/30, Hein) reports on a study presented at an RSNA meeting arguing “abbreviated MRI protocols could dramatically improve the diagnosis of breast cancer and lead to the earlier diagnosis of a lot more women, especially those with fast-growing cancers.” Christiane Kuhl, MD, from University of Aachen in Germany, who presented, said that MRI is “by far the most accurate imaging method for diagnosis.” The study included “1,450 women with dense breast tissue who are at average risk for breast cancer.” Kuhl explains that while “a typical MRI study takes up to 40 minutes and generates several hundred images,” the abbreviated form “has a 3-minute magnet time and an abridged image interpretation time (about 30 seconds), generates only one precontrast and one postcontrast T1 weighted image set, and uses maximum-intensity projections to fuse the first postcontrast subtracted images into one single high-contrast image.”

Risk-Based Mammographic Screening Would Delay Detection

Wednesday, November 22, 2017

The Radiology Business Journal (11/21, Walter) reports a new study claims that risk-based mammographic screening for breast cancer could delay detection and treatment of breast cancer in many cases. The study authors wrote, “We found that many screen-detected breast cancers occurred in women without family history or dense breast tissue.” Specifically, they said that “in 44 percent of patients, neither dense breast tissue nor family history of breast cancer was seen.” The findings were published in the American Journal of Roentgenology.

Risk-Based Mammographic Screening Would Delay Detection Of Many Breast Cancers, Study Claims.

Wednesday, November 22, 2017

The Radiology Business Journal (11/21, Walter) reports a new study claims that risk-based mammographic screening for breast cancer could delay detection and treatment of breast cancer in many cases. The study authors wrote, “We found that many screen-detected breast cancers occurred in women without family history or dense breast tissue.” Specifically, they said that “in 44 percent of patients, neither dense breast tissue nor family history of breast cancer was seen.” The findings were published in the American Journal of Roentgenology.

Risk-Based Mammographic Screening Would Delay Detection Of Many Breast Cancers Study Claims.

Tuesday, November 21, 2017

The Radiology Business Journal (11/21, Walter) reports a new study claims that risk-based mammographic screening for breast cancer could delay detection and treatment of breast cancer in many cases. The study authors wrote, “We found that many screen-detected breast cancers occurred in women without family history or dense breast tissue.” Specifically, they said that “in 44 percent of patients, neither dense breast tissue nor family history of breast cancer was seen.” The findings were published in the American Journal of Roentgenology.

RSS
135678910Last